The episodic cluster headache trial included a total of 106 patients with an average of 17.5 cluster headache attacks per week at baseline.
Patients with cluster headaches present differently depending on whether they have ever been exposed to tobacco.
The United States Cluster Headache Survey assessed tobacco exposure in individuals with cluster headaches.
Clinicians discuss the clinical implications of headache and comorbid sleep disturbances.
Emerging evidence suggests that sphenopalatine ganglion stimulation may be an effective treatment for refractory cluster headache.
In episodic cluster headaches, acute noninvasive vagus nerve stimulation led to significantly higher rates of participants without pain.
A recently published article exposes a gaping hole in the access to an effective first-line therapy for a portion of patients with cluster headache in the United States.
Cluster headaches are considered the most severe headache type and the most difficult to treat. In 2016, the American Headache Society released new evidence-based guidelines for the treatment of cluster headache.
Tobacco use, alcohol consumption, age at disease onset, and sleep quality are predictors of cluster headache severity.
Results of a recent study found that the current costs of medical grade oxygen for use in the treatment of cluster headache are not "prohibitively expensive" for either healthcare insurance providers or for patients.
Local and painful symptoms and signs and general symptoms occur frequently prior to cluster headache attacks.
gammaCore, a hand-held device for treating episodic cluster headaches via mild electrical stimulation of the vagus nerve is now available in the United States.
The FDA has approved the use of gammaCore, the first handheld, non-invasive device to treat pain associated with episodic cluster headaches in adults.
Headaches are a common complaint in primary care, and they are often connected to sleep in a variety of ways.
Treatment of cluster headache by sphenopalatine ganglion stimulation has long-term benefits in the prevention of attacks.
Clinical Pain Advisor Articles
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Stat Consult: Chronic Low Back Pain
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Methadone Improves Short-Term Outcomes Better Than Morphine in Neonatal Abstinence Syndrome
- Addressing Rare Headache Disorders: Acute Confusional Migraine
- Hospital-Owned Practices Associated With Positive Workplace Perceptions Among Staff
- Optimal Strategies for Opioid Weaning After Ambulatory Surgery
- Chinese Traditional Medicine Showed Effectiveness on Pain, Quality of Life in Advanced Cancer